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Objectives. This study sought o evaluate changes in early 
morbidity and mortality as well as predictors of outcome in our 
must recent 339 patients undergoing modified Fontan operations. 
Background. The Fontan operation is the preferred efinitive 
palliation for patients with functional single ventricles. Previously 
reported early mortality rates after Fontan operation have been 
substantial. 
Methods. Records of 339 consecutive patients who had a Fontan 
operation at the Mayo Clinic between 1987 and 1992 (recent 
cohort) were reviewed. This cohort was compared with the previ- 
ous 500 patients who had Fontan operations performed between 
1973 and 1986 (early cohort). 
Results. Recently, overall early mortality after Foutan has 
decreased significantly compared with that for the early cohort 
(from 16% to 9%, p = 0.002). This decline occurred despite 
increased anatomic omplexity ofpatients. Short-term posthospi- 
tal survival has also improved significantly in recent patients. 
One-year survival improved to 88% from 79%, and 5-year survival 
to 81% from 73% (p = 0.006). Patients with common atrioventric- 
ular valves and those who took daily preoperative diuretic medi- 
cation or had either postoperative r nal failure or elevated 
postbypass right atrial pressure were at increased risk for early 
mortality. Young age was not found to be a risk factor for early 
mortality. Early mortality for patients with heterotaxia decreased 
dramatically: recent 30-day mortality was 15% compared with 41% 
in the early heterotaxy cohort. 
Conclusions. Many factors may have contributed to decreased 
early mortality after Fontan. Improved patient selection, younger 
age at time of operation, refinements in surgical techniques and 
postoperative management may all have had important roles. 
Proposed technical modifications of the Fontan operation must be 
evaluated in light of these improved results. 
(JAm Coil Cardiol 1996;28:480-6) 
In 1971, Fontan and colleagues (1) reported the first successful 
total right heart bypass that separated the pulmonary and 
systemic irculations and relieved ventricular volume overload 
in patients with tricuspid atresia. Recently, revised selection 
criteria have been suggested, and many technical modifications 
of the Fontan operation have been proposed (2-14). Some of 
these modifications (4,5) involve a persistent interatrial com- 
munication ("fenestration") that allows an ongoing right-to- 
left shunt. Because these most recent modifications represent 
a major change in approach to these patients, it seemed that a 
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reassessment of early postoperative r sults of the nonfenes- 
trated Fontan operation was indicated. Therefore, we studied 
the clinical course and outcomes of a recent cohort of patients 
(n = 339) who had Fontan operations at the Mayo Clinic 
(operations performed from 1987 to 1992). This cohort was 
then compared to our previously reported results in patients 
who had Fontan operations before 1987 (n = 500). In addition, 
an attempt was made to identify factors that currently were 
predictive of early mortality. 
Methods  
Patients. Clinical data from outpatient records and hospi- 
tal charts were reviewed for all 339 patients who had a Fontan 
operation at the Mayo Clinic between January 1, 1987, and 
December 31, 1992 ("recent cohort"). These results were 
compared with similar data obtained from the first 500 patients 
who had a Fontan operation at the Mayo Clinic between 1973 
and 1986 (this group is referred to as the "early cohort") 
(3,6-10). These data were available in an existing computer- 
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ized data base. None of the patients in either cohort had atrial 
fenestration at the time of the Fontan operation. 
Measurements. Data from patient records, preoperative 
echocardiograms and cardiac catheterizations were reviewed 
to assess factors that have been described previously as possi- 
bly being predictive of early mortality after Fontan operation 
(a list of all variables analyzed appears in a footnote in the 
Results section). Arrhythmias were documented by surface 
electrocardiogram, Holter monitoring or rhythm strip tracings. 
Early mortality was defined as death occurring at any time 
before hospital discharge or within 30 days after operation 
(even if the patient had been discharged). The day of operation 
was considered ay i for calculating the length of hospital stay, 
intubation and chest ube drainage. The duration of chest ube 
drainage was "prolonged" if it continued beyond 14 days. The 
hospital stay was "prolonged" after 21 days. Postoperative 
mean right atrial pressure was measured after the discontinu- 
ation of cardiopulmonary b pass but before sternal reapproxi- 
mation. Renal failure was defined as the need for peritoneal 
dialysis or hemodialysis. Impaired hepatic function was defined 
as clinical jaundice associated with elevated serum transami- 
nase levels. 
Follow-up. Follow-up regarding vital status of hospital 
survivors was obtained by reviewing outpatient records, corre- 
spondence letters and vital status questionnaires. Survival 
beyond the last patient contact was not assumed. 
Statistical analysis. All the factors described in previous 
Mayo Clinic publications (3,6-10) as being predictive of early 
mortality were analyzed as possible predictors of outcome in 
the recent cohort. In addition, type of Fontan connection and 
pacemaker placement were also assessed as possible predictors 
of outcome. Univariate assessment of the association of vari- 
ables with mortality was performed using chi-square and 
Wilcoxon rank-sum tests. Univariate comparisons of variables 
that differentiated the recent cohort from the early cohort were 
performed with the same tests. Cumulative actuarial survival 
was estimated using the Kaplan-Meier method (15). For the 
multivariate assessment of factors potentially associated with 
early mortality, the preoperative and perioperative or postop- 
erative variables used were those indicated to be univariately 
associated with early mortality. Multivariate analysis was per- 
formed using the logistic regression procedures available in the 
SAS statistical analysis system (16). A stepwise, backward 
elimination of the nonsignificant variables was performed 
using a p value cut point to retain variables with p < 0.02. For 
all other comparisons, two-tail p values -<0.05 were taken as 
evidence of findings not attributable to chance. 
Resu l ts  
Patients. The recent cohort consisted of 339 patients (202 
boys [60%], 137 girls [40%]). Median age at time of surgery 
was 7 years (range 9 months to 38 years; mean 9.3 years). 
Sixty-three patients (19%) had tricuspid atresia; 72 (21%) had 
double-inlet left ventricle; 62 (18%) had a heterotaxy syn- 
drome (asplenia 34 [10%]; polysplenia 28 [8%]); and 142 
Table 1. Early Mortality After Fontan Operation According to 
Cardiac Lesion in Patients With Operation From 1987 to 1992 
No. (%) of Early 
Lesion Patients Mortality* 
Tricuspid atresia 63 (19%) 3/63 (5%) 
Double-inlet left ventricle 72 (21%) 4/72 (6%) 
Polysplenia 28 (8%) 4/28 (14%) 
Asplenia 34 (10%) 5/34 (15%) 
Pulmonary atresia, IVS 18 (5%) 1/18 (6%) 
Double-inlet right ventricle 13 (4%) 1/13 (8%) 
DORV or TGA with AVV hypoplasia 36 (I1%) 1/36 (3%) 
UVH with AVV atresia 32 (9%) 5/32 (16%) 
Other 43 (13%) 6/43 (14%) 
Total 339 (100%) 30/339 (9%) 
*No significant differences in mortality rate between groups (see text for 
definition of early mortality). AVV = atrioventricular valve; DORV = double- 
outlet right ventricle; IVS = intact interventricular septum; TGA = transposition 
of the great arteries; UVH = univentricular heart. 
(42%) had other complex forms of functional single ventricle. 
Overall, early mortality for the recent cohort was 30 (9%) of 
339. Early mortality is described according to each cardiac 
lesion in Table 1. Patient age, gender and cardiac lesion were 
not significantly predictive of early mortality after Fontan 
operation. 
Comparison of early and recent cohorts. Early mortality 
after Fontan operation significantly decreased in the recent 
cohort compared to the early cohort (30 [9%] of 339 vs. 81 
[16%] of 500, p = 0.002). Patients in the recent cohort were 
significantly ounger (median 7years, range 1 to 38) than those 
in the early cohort (median 10 years, range 1 to 42, p < 0.001). 
There were more patients with complex anatomy (not tricuspid 
atresia or double-inlet left ventricle) in the recent cohort than 
in the early group (60% vs. 36%, p < 0.001). The hemody- 
namic features of both cohorts were similar (Table 2). The only 
statistically significant differences in hemodynamic values be- 
tween the two cohorts were preoperative ventricular end- 
diastolic pressure and postoperative mean right atrial pressure. 
The early cohort had more patients in the high extreme of the 
range for these pressures, although the means and medians 
were similar. 
Univariate analysis of factors affecting early mortality in 
the recent cohort. Preoperative factors. Preoperative factors 
that were significantly associated with early mortality by uni- 
variate analysis are listed in Table 3. Those factors included 
cardiothoracic ratio >0.60, ambiguous atrial situs, common 
atrium, common atrioventricular valve, total anomalous pul- 
monary venous connection and daily diuretic therapy. 
Postoperative factors. Intraoperative and postoperative fac- 
tors affecting early mortality by univariate analysis included 
atrioventricular valve repair or replacement, mean right atrial 
pressure (immediately postoperative) >20 mm Hg and the 
postoperative occurrence of any of the following: pericardio- 
centesis, supraventricular tachycardia, renal failure or im- 
paired hepatic function (Table 3). A "lateral tunnel"-type 
anastomosis was performed in 55% of patients (187 of 339) in 
482 CETTA ET AL. JACC Vol. 28, No. 2 
FONTAN OPERATION OUTCOMES August 1996:480-6 
Table 2. Hemodynamic Variables in Early and Recent Cohorts 
Early Cohort Recent Cohort 
Variable (1973-1986) (1987-1992) p Value 
Preoperative 
PAP (ram Hg) 17 (4-65) 17 (5-65) NS 
19+.9 18+_8 
RPA (Um 2) 1.5 (0.1-6.1) 1.3 (0.1-6.6) NS 
1.6 _+ 1.0 1.5 +_ 0.9 
VEDP (ram Hg) 13 (l-34) 12 (2-27) 0.002" 
13+_5 12+_4 
EF (%) 58 (6-82) 55 (30-84) NS 
56 +_ 12 55 +_ 10 
C/I" ratio 0.55 (0.35-0.82) 0.57 (0.36-0.81) NS 
0.56 +_ 0.08 0.57 +_ 0.07 
Operative 
RAP (ram Hg) 18 (8-34) 18 (10-28) < 0.001' 
18 + 3 17 + 2.5 
Bypass time (rain) 122 (50-384) 133 (57-346) < 0.001 
130 +_ 43 142 : 49 
*Significantly different, Wilcoxon rank sum test; statistical significance was 
achieved because the high extreme of the range for these variables was lower in 
the recent cohort, although the mean and median values in the early and recent 
cohorts were similar. Data presented are median (range) or mean value _+ SD. 
C/T = cardiothoracic ratio; EF = ejection fraction; PAP - pulmonary artery 
pressure; RAP - right atrial pressure; RPA = pulmonary arteriolar resistance; 
VEDP - ventricular end-diastolic pressure. 
the recent cohort. This type of connection did not affect early 
mortality in either a positive or negative way, nor did pro- 
longed hospitalization or prolonged chest tube drainage. Nu- 
merous other preoperative and postoperative factors were 
analyzed and were not found to significantly influence early 
mortality.* 
Multivariate analysis of factors affecting early mortality in 
recent cohort. Multivariate assessment was performed as out- 
lined in Methods. Initial candidate predictors were all of the 
variables found to be associated with early death by univariate 
analysis (Table 3). By use of logistic regression, a stepwise, 
* Preoperative factors analyzed were age, gender, primary cardiac lesion, 
cardiothoracic ratio >0.60, heterota~, previous urgical procedures, history of 
arrbytbmia, use of antiarrhythmic or diuretic medications, pulmonary artery 
distortion, nonconfluent pulmonary arteries, aortic/subaortic stenosis, pulmo- 
nary valve stenosis or atresia, cardiac position, ambiguous atrial situs, presence of 
common atrium, presence of common atrioventricular valve, total anomalous 
pulmonary venous connection, coronary artery anomalies, anomalies of systemic 
venous connection, partial anomalous pulmonary venous connection, ventricular 
morphology, pulmonary arteriolar resistance, ventricular end-diastolic pressure, 
ventricular ejection fraction, "Fontan index" (9), coarctation (present or re- 
paired), juxtaposed atrial appendages and atrioventricular or pulmonary valve 
closure. 
Postoperative factors analyzed were type of Fontan connection, ventricular 
or supraventricular ar hythmias, complete heart block, cardiopulmonary b pass 
time, cross-clamp time, temporary atrial or ventricular pacing, permanent 
pacemaker placement, pulmonary artery confluence restoration, pulmonary 
artery angioplasty, mean right and left atrial pressure, systemic blood pressure, 
subaortic resection, chylous pleural effusion, reoperation for tracheotomy, stroke 
or seizure, hemidiaphragm paralysis, reoperation for bleeding, reoperation for 
right atrial thrombus, reoperation for thoracic duct ligation, pericardiocentesis, 
reoperation for atrial patch dehiscence, reoperation for conduit obstruction, 
antiarrhythmic medication use, tboracentesis, postoperative r nal failure and 
postoperative impaired hepatic function. 
Factors associated with early mortality are also listed in Table 3. 
backward elimination of the nonsignificant variables was per- 
formed. The p value cut point to retain variables was <0.02. 
This resulted in three variables being identified as multivariate 
risk factors for early death: postoperative r nal failure (p < 
0.001), postoperative right atrial pressure greater than 
20 mm Hg (p = 0.008) and the presence of a common 
atrioventricular valve (p = 0.017). 
There were 230 patients with none of these three risk 
factors. Early mortality was 3% (7 of 230) in this group. Of 48 
patients with common atrioventricular valve but normal renal 
function and right atrial pressure less than 20 mm Hg, there 
was no early mortality (0%). Twelve patients had right atrial 
pressure levated above 20 mm Hg as a sole multivariate risk; 
there was one early death (8%) in this group. Twenty patients 
had renal failure alone, and there were five early deaths (25 %). 
Nineteen had renal failure and at least one of the two other 
variables present, and 14 (74%) of these patients died. Of five 
patients with a common atrioventricular valve and elevated 
right atrial pressure, there were two early deaths (40%). 
Presence of postoperative supraventricular tachycardia met 
the usual criteria of significance (p < 0.05), but in light of the 
number of variables considered, and because this factor was 
only marginally significant by univariate analysis (p = 0.044, 
Table 3), it was not included as a significant multivariate 
predictor. 
In order to assess which preoperative factors were indepen- 
dently associated with early mortality, a separate multivariate 
analysis was performed. This analysis included only the "pre- 
operative" factors (see Table 3) found to be significantly 
associated with early mortality by univariate analysis (i.e., 
information known to the clinician during the preoperative 
evaluation). Statistical methods used were identical to those 
used for the overall analysis described above. Two of the 
preoperative ariables were found to be independently associ- 
ated with an increased risk of early mortality. They were the 
presence of a common atrioventricular valve (p < 0.001) and 
daily diuretic therapy (p = 0.007). There were 225 patients 
who had neither of these risk factors, and early mortality in this 
group was 4.9% (11 of 225). Forty-five patients were on daily 
diuretic therapy but did not have common atrioventricular 
valves; early mortality in this group was 11.1% (5 of 45). 
Fifty-nine patients had common atrioventricular valves but 
were not on daily diuretic medication; early mortality in these 
patients was 15.3% (9 of 59). When both risk factors were 
present in the same patient, early mortality was 50% (5 of 10). 
Influence of age on early mortality. In the recent cohort, 
20% of patients (69 of 339) were under 4 years old, and early 
mortality in this subgroup was 13% (9 of 69); 34 (10%) of 339 
patients were younger than 3 years old, and early mortality for 
these patients was 9% (3 of 34). This was a significant decrease 
in mortality for patients less than 4 years of age compared with 
the early cohort (14 [27%] of 51, p = 0.047) (10). In the recent 
cohort, early mortality for patients <4 years old was not 
significantly different from early mortality for older patients 
(21 [8%] of 270). 
In the recent cohort, 46 of 339 patients (14%) were adults 
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Table 3. Preoperative and Postoperative Factors Associated With Early Mortality After Fontan 
Operation i  the Recent Cohort 
p Value 
Preoperative 
Univariate Multivariate Multivariate 
Factor No. (%) EM (%) Analysis Analysis Analysis 
Preoperative 
C/T ratio >0.60 232 (68%) i1% 0.026 NS NS 
Ambiguous atrial situs 52 (15%) 17% 0.020 NS NS 
Common atrium 57 (17%) 19% 0.002 NS NS 
Common AV valve 69 (20%) 20% < 0.001 0.017 < 0.001 
Total anomalous pulmonary, venous 41 (12%) 20% 0.010 NS NS 
connection 
Daily diuretic therapy 55 (16%) 18% 0.008 NS 0.007 
Postoperative 
AV valve repair/replacement 68 (20%) 16% 0.017 NS - -  
Mean RAP >20 mm Hg 23 (7%) 30% < 0.001 0.008 - -  
Pericardiocentesis 31 (9%) 26% < 0.001 NS - -  
Supraventricular t cbycardia* 107 (32%) 13% 0.044 NS - -  
Renal failure 39 (12%) 49% < 0.001 < 0.001 - -  
Impaired hepatic function 17 (5%) 35% < 0.001 NS - -  
Total 339 (100%) 9% 
*Atrial flutter, atrial fibrillation, atrial tachycardia or accelerated junctional rhythm. AV = atrioventricular; EM = 
early mortality; other abbreviations a in Table 2. 
(age ---18 years), and early mortality was 5 (11%) of 46. This 
rate was not significantly different when compared with either 
early mortality in recent younger patients (25 [9%] of 293) or 
with results from the early cohort (5 [6.5%] of 77). Patient age 
was not significantly associated with arrhythmias, length of 
hospitalization, duration of chest tube drainage or need for 
reoperation. 
Heterotaxy. There were 62 patients with either asplenia or 
polysplenia in the recent cohort. Early mortality was 14.5% in 
this group. Atrioventricular valve regurgitation was signifi- 
cantly more common in heterotaxy patients than in nonhetero- 
taxy patients (54 [87%] of 62 vs. 139 [50%] of 277, p < 0.001). 
Also, need for atrioventricular valve repair or replacement 
during the Fontan operation was more common in heterotaxy 
than nonheterotaxy patients (45% vs. 14%, p < 0.001). In 
heterotaxy patients without concurrent atrioventricular valve 
repair or replacement, early mortality was not significantly 
different from the early mortality observed in nonheterotaxy 
patients (9% vs. 7%, p = 0.7). Postoperative supraventricular 
tachyarrhythmias ( trial flutter, atrial fibrillation, atrial tachy- 
cardia and accelerated junctional rhythm) were significantly 
more common in heterotaxy patients compared with nonhet- 
erotaxy patients (45% vs. 29%, p = 0.008). 
Heterotaxy: comparison of early and recent cohorts. In the 
early cohort, 49 (10%) of 500 patients had a heterotaxy 
syndrome (23 asplenia, 26 polysplenia). In the recent cohort, 
the proportion of patients with heterotaxy syndromes in- 
creased to 18% (62 of 339) (34 asplenia, 28 polysplenia). In the 
recent heterotaxy group, early mortality decreased significantly 
to 14.5% (9 of 62) as compared to the early heterotaxy patients 
(21 [43%] of 49, p = 0.001). In the early cohort, asplenia 
carried a greater risk for early mortality than polysplenia (61% 
vs. 27%). In the recent cohort, there was no difference inearly 
mortality between patients with asplenia (5 [15%] of 34) and 
polysplenia (4 [14%] of 28). 
Arrhythmias. Tachyarrhythmias. Preoperatively, 46(14%) 
of 339 patients had a history of tachyarrhythmia. Preoperative 
history of tachyarrhythmia did not correlate with increased 
early mortality. During the postoperative hospitalization, 32% 
of patients (107 of 339) had postoperative supraventricular 
tachyarrhythmias ( trial flutter, atrial fibrillation, atrial tachy- 
cardia or accelerated junctional rhythm), and only 8% of 
patients (27 of 339) had a postoperative ntricular arrhyth- 
mia. In the multivariate analysis, postoperative supraventricu- 
lar tachyarrhythmia w s weakly correlated with increased risk 
of early mortality after Fontan operation (p = 0.033, Table 3). 
However, the degree of significance was considered to be 
borderline because of the number of variables considered and 
the variable selection process that was employed. Although 
40% of patients in the recent cohort had transient postop- 
erative tachyarrhytfimias, only 41 (13%) of 311 required an 
antiarrhythmic medication other than digoxin at the time of 
hospital discharge. 
Bradyarrhythmias. In the recent cohort, complete heart 
block was present in ll (3%) of 339 patients before the Fontan 
operation. Complete heart block developed inan additional 12 
(4%) of 328 patients during the Fontan hospitalization. 
Twenty-two percent of patients (73 of 339) required prolonged 
(>5 days) temporary pacing for sinus node dysfunction or 
junctional rhythm in order to maintain adequate cardiac 
output. A permanent pacemaker was placed or replaced in 17 
patients (6%) during the Fontan hospitalization. Neither pace- 
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Figure 1. Survival curves after Fontan operation comparing the early 
cohort and the recent cohort. The recent cohort demonstrated signif- 
icantly improved early survival (p = 0.006). 
.~> 
03 
I -- ~ Early cohort (n =49), 1973-86 
8O 
[ - - I _  1 _ ~ - -L  . . . .  
40 t --1 
2O 
0 
9 ; ; 1'o 
I t 
30days 6 mo Years  
Figure 2. Survival curves after Fontan operation for heterotaxy pa- 
tients, comparing the early and recent cohorts. The recent cohort 
demonstrated significantly improved early survival (p < 0.001). 
maker placement nor prolonged temporary pacing was associ- 
ated with increased early mortality. 
Hospital course. Median duration of hospitalization was 14 
days (range 7 to 86). Median duration of intubation was 3 days 
(range 1 to 75). Median duration of chest ube drainage was 12 
days (range 4 to 72). In 123 (36%) of 339 patients, chest ube 
drainage was prolonged (>14 days), and in 81 (24%) of 339 
patients, the hospital period was prolonged (>21 days). Reop- 
eration (including reexploration for bleeding) during the Fon- 
tan hospital period was necessary in 54 (16%) of 339 patients. 
The only reoperation that was significantly associated with 
early mortality was take-down of the Fontan connection (p = 
0.001). Three of four patients (75%) in the recent cohort who 
had a take-down died. 
Short-term follow-up. Follow-up information was available 
for 285 (92%) of 309 patients who survived to hospital 
discharge or for at least 30 days postoperatively. Mean dura- 
tion of follow-up was 2.2 years (range 0.02 to 6.7). Overall, the 
6-month actuarial survival estimate was 90%, 1-year survival 
was 88%, and 5-year survival was 81% for the recent cohort 
(Fig. 1). The five-year survival estimate in the recent cohort 
was significantly (p = 0.006) improved compared with that for 
the early cohort. In the early series, 6-month survival was 81%, 
1-year survival was 79%, and 5-year survival was 73% (Fig. 1). 
Short-term survival after Fontan operation for heterotaxy 
patients in the recent cohort improved significantly (p < 0.001) 
compared with survival of heterotaxy patients in the early 
cohort (6-month survival 84% vs. 57%; 1-year survival 78% vs. 
53%; 5-year survival 73% vs. 42%) (Fig. 2). 
Short-term survival after Fontan operation for young pa- 
tients (<4 years) in the recent cohort was significantly (p = 
0.01) improved compared with the early cohort (6-month 
survival 82% vs. 65%; 1-year survival 82% vs. 63%; 5-year 
survival 82% vs. 59%) (Fig. 3). 
Discuss ion  
Risk factor analysis. In 1977, Choussat and colleagues (11) 
described 10 criteria for selecting patients for the Fontan 
operation. Subsequent experience has shown that many of 
these criteria should be considered to be risk factors for but not 
absolute contraindications to the Fontan operation. Our recent 
experience demonstrated that patients with common atrioven- 
tricular valves, those requiring daily diuretic therapy and 
patients with specific postoperative problems (mean right atrial 
pressure >20 mm Hg or renal failure) were at significant risk 
for increased early mortality. No other factors were signifi- 
cantly predictive of early mortality in the multivariate analyses 
performed in this study. However, this does not imply that 
traditional preoperative risk factors (such as pulmonary artery 
hypoplasia, decreased ventricular ejection fraction, increased 
ventricular end-diastolic pressure, increased pulmonary artery 
pressure and increased pulmonary arteriolar esistance) are 
unimportant. In fact, they are likely to be at least as important 
as the risk factors identified in this study. Indeed, few patients 
with these previously defined "high risk" characteristics were 
selected for Fontan operation in the recent cohort. 
Younger age at the time of Fontan operation may contrib- 
ute to the improved survival observed in this study (17). Young 
patients, specifically those under 4 years old, have been 
reported to experience increased early mortality after Fontan 
operation (10). However, during the last 20 years, early 
mortality after Fontan for young patients has decreased pro- 
Figure 3. Survival curves after Fontan operation for children <4 years 
old, comparing the early and recent cohorts and showing significantly 
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gressively to the current rate of 13% for those <4 years old and 
to 9% for those <3 years old. Many factors may have contrib- 
uted to the improved early outcome in young patients. For 
example, in the early cohort, 37% of patients younger than 4 
years had a Fontan operation on a nonelective basis because of 
progressive clinical deterioration. In the recent cohort, all 
patients were operated electively and, therefore, represent 
better candidates and had fewer complicating factors. Previous 
staging operations (i.e., cavopulmonary connections) may fa- 
vorably influence early mortality after Fontan operation 
(18,19). However, the number of patients in the recent cohort 
who had previous cavopulmonary connections was small (24 
unilateral, 6bidirectional) and, thus, was not subject o mean- 
ingful statistical analysis. 
Heterotaxy and related syndromes. The Fontan operation 
is the preferred form of definitive palliation for patients with 
complex cyanotic heart disease associated with the heterotaxy 
syndromes. In the recent cohort, early mortality after Fontan 
for heterotaxy patients has decreased ramatically compared 
to the early cohort (14.5% vs. 43%). Many factors, including 
the use of an intraatrial conduit o route hepatic venous and 
inferior vena caval blood flow to the pulmonary arteries, may 
have contributed to these improved results. In the early cohort, 
patients with asplenia had increased early mortality compared 
with patients with polysplenia (61% vs. 27%). But in the recent 
cohort, early mortality after Fontan operation is similar in 
these two subsets of patients (asplenia, 15% vs. polysplenia, 
14%). 
Atrioventricular valve repair. Atrioventricular valve repair 
or replacement, a recognized risk factor for early mortality, 
was required more frequently in heterotaxy than nonhetero- 
taxy patients (45% vs. 14%). If one controls for atrioventricu- 
lar valve repair or replacement, then the outcomes observed in 
recent patients with heterotaxy are similar to those in patients 
without heterotaxy syndromes. Patients with heterotaxy syn- 
dromes who did not have atrioventricular valve procedures had 
early mortality of 9%, compared to 21% in heterotaxy patients 
who had atrioventricular valve procedures. 
Nonfenestrated versus fenestrated approach. The length 
of the hospital stay (median 14 days) observed in the recent 
cohort is similar to that reported by medical centers that 
routinely perform atrial fenestration (4,20-22). However, no 
patient in the present series had an atrial fenestration per- 
formed. In the recent cohort, 36% of patients had chest tube 
drainage that was defined as prolonged (>14 days), and 24% 
of patients were hospitalized for longer than 21 days. It 
appears that centers that routinely perform fenestration have 
lower rates of prolonged chest tube drainage and fewer 
prolonged postoperative hospital stays (4,20-22). However, 
comparison of results from different centers is difficult for 
many reasons, including differences in surgical techniques and 
postoperative care and, most importantly, patient selection and 
heterogeneity. It is unclear whether the reduction in initial 
hospital stay and duration of chest tube drainage justifies the 
potential morbidity (including risk of paradoxic embolization 
and desaturation) from a persistent postoperative right-to-left 
shunt and the added economic ost of subsequent a rial baffle 
fenestration closure. 
It seems that it would still be difficult to predict which 
patients would benefit from atrial baffle fenestration, as most 
patients have a satisfactory esult without fenestration. In most 
instances, postoperative management can be successfully ac- 
complished with hemodynamic adjustments, prevention of 
acidosis and pharmacologic manipulation of the pulmonary 
vasculature, including the potential benefits of inhaled nitric 
oxide. Perhaps for these reasons, atrial baffle fenestration is
best reserved for patients who have right atrial pressures 
->20 mm Hg after cessation of cardiopulmonary b pass and 
optimization of hemodynamic variables. 
Short-term follow-up. Information regarding vital status 
was available for 92% of patients in the recent cohort. Al- 
though there is ongoing risk for late morbidity and mortality 
after Fontan operation, the short-term survival for recent 
Fontan patients has improved markedly. Current 1-year sur- 
vival was 88%, and 5-year survival was 81%. By comparison, 
1-year and 5-year survival in the early cohort was 79% and 
73%, respectively. Also, short-term survival for heterotaxy 
patients, a recognized "high-risk" subgroup, has also improved 
dramatically (1-year survival 78%; 5-year survival 73%) com- 
pared with the early cohort (1-year survival 53%; 5-year 
survival 42%). 
Conclusions. Early and short-term survival after the non- 
fenestrated Fontan operation have improved ramatically de- 
spite the increased anatomic omplexity and younger age of 
the recent cohort of patients. In the recent cohort, early 
survival, even for traditionally high risk heterotaxy syndrome 
patients, has improved significantly. Also, young age (between 
2 and 4 years of age) no longer increases operative risk for 
Fontan patients. Many factors may have contributed to the 
improvement in early and short-term survival that was ob- 
served. Because many of these changes were subtle and tended 
to evolve continuously, the factors most responsible for these 
improvements could not be specifically identified by retrospec- 
tive statistical analysis. It is possible that improved patient 
selection, younger age at time of operation, refinements in 
surgical techniques and changes in postoperative management 
have all contributed. Any major technical modification of the 
Fontan operation must be evaluated in light of the improved 
outcomes observed after nonfenestrated Fontan operations in 
the recent cohort. 
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